St Peter Steven 4/A
4/A · ARATANA THERAPEUTICS, INC. · Filed May 1, 2018
Insider Transaction Report
Form 4/AAmended
St Peter Steven
DirectorPRESIDENT AND CEO
Transactions
- Sale
Common Stock
2018-04-30$5.00/sh−11,513$57,582→ 660,746 total
Footnotes (3)
- [F1]This Form 4/A has been filed solely to change the code reported in Column 4 of Table I of the Reporting Person's Form 4 filed on April 30, 2018, which had inadvertently noted an "A" instead of "D" to reflect a disposition of the Issuer's common stock, due to an administrative error.
- [F2]The sale reported in this Form 4 was effected pursuant to a 10b5-1 plan adopted by the Reporting Person on September 13, 2017.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.99 to $5.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.